|
Press Release Webcast July 16
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2020 05:35PM
|
|
Re: Interesting New Lipid Standards
|
3
|
Resverlogix Corp.
|
Jul 27, 2022 07:15AM
|
|
Re: RVXCF short number down again 7.64% as of Oct 14th
|
3
|
Resverlogix Corp.
|
Oct 26, 2022 03:47PM
|
|
Re: 3rd Qtr MD&A & Financials
|
3
|
Resverlogix Corp.
|
Jan 09, 2024 12:27PM
|
|
Re: RVX's place in therapy - future prediction
|
3
|
Resverlogix Corp.
|
Mar 14, 2021 12:57PM
|
|
More Exempt Distribution Investments
|
3
|
Zenith Epigenetics
|
Jan 05, 2024 02:49PM
|
|
BTI just filed a Other securityholders documents - English
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 16, 2018 10:29AM
|
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Jan 11, 2019 01:35PM
|
|
Another Exempt Distribution -2022-06-02
|
3
|
Resverlogix Corp.
|
Jun 05, 2022 10:25AM
|
|
Re: a new study that one researcher called "stunning."
|
3
|
Resverlogix Corp.
|
Feb 11, 2022 11:15AM
|
|
Re: Compensation Commity
|
3
|
Resverlogix Corp.
|
Mar 28, 2021 02:17PM
|
|
Warrants: RVX.WT.A
|
3
|
Resverlogix Corp.
|
Apr 10, 2023 01:01PM
|
|
Re: Secured $6M Convertable Debenture
|
3
|
Resverlogix Corp.
|
Apr 15, 2024 10:32AM
|
|
Re: Ya never know
|
3
|
Resverlogix Corp.
|
Apr 11, 2020 09:08AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 16, 2022 06:46AM
|
|
Re: This Zacks piece is Dated April 10th....
|
3
|
Resverlogix Corp.
|
Apr 11, 2019 06:47AM
|
|
Re: Clinical trials site
|
3
|
Zenith Epigenetics
|
Aug 20, 2022 07:25AM
|
|
Re: Report Of Exempt Distribution.
|
3
|
Zenith Epigenetics
|
Apr 17, 2024 04:17PM
|
|
Re: if the partial sale of zen
|
3
|
Resverlogix Corp.
|
Aug 01, 2024 04:44PM
|
|
Re: RRR %
|
3
|
Resverlogix Corp.
|
Jul 01, 2019 12:47PM
|
